Clinical Trials Directory

Trials / Completed

CompletedNCT00590525

Inflammation as a Predictor in Cardioversion of Atrial Fibrillation

Status
Completed
Phase
Study type
Observational
Enrollment
45 (actual)
Sponsor
Creighton University · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The laboratory test, C-Reactive Protein (CRP), has become well established as a marker of inflammation. Recently a high CRP level (indicating an increase in inflammation) was identified as a risk factor for atrial fibrillation. We are conducting this study with patients such as yourself with atrial fibrillation who are planning to undergo cardioversion to determine what sort of relationship exists between CRP levels and atrial fibrillation. We will then look at success rates of converting atrial fibrillation to normal sinus rhythm, compared to patients' CRP levels.

Conditions

Interventions

TypeNameDescription
PROCEDURECardioversionBaseline hsCRP will be drawn the morning of, prior to, cardioversion. An EKG to document the patient's rhythm will be obtained at the one-month mark

Timeline

Start date
2004-10-01
Primary completion
2009-06-01
Completion
2009-06-01
First posted
2008-01-10
Last updated
2009-12-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00590525. Inclusion in this directory is not an endorsement.

Inflammation as a Predictor in Cardioversion of Atrial Fibrillation (NCT00590525) · Clinical Trials Directory